Von Hippel‐Lindau Syndrome

Brain Pathology

Volumn 5, Issue 2, 1995, Pages 181-193

  Neumann, Hartmut P H ^a   Lips, Cornells J M ^b   Hsia, Y Edward ^c   Zbar, Berton ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF HAWAII   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; GENE MUTATION; HISTOLOGY; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

BRAIN; HIPPEL-LINDAU DISEASE; HUMAN;

EID: 0028998344     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1995.tb00592.x     Document Type: Article

References (92)

1. Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas
2. Use of gadolinium‐enhanced magnetic resonance imaging in the diagnosis and management of posterior fossa hemangioblastomas
3. Familial pheochromocytoma, hypercalcemia and von Hippel‐Lindau disease. A ten year study of al large family
4. Pancreatic cystadenoma in von Hippel‐Lindau disease; an unusual cause of pancreatic and common bile duct obstruction
5. Islet cell tumor in von Hippel‐Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias
6. Choroid plexus papilloma. A new presentation of von Hippel‐Lindau (VHL) disease
7. Central nervous system haemangioblastoma: a clinical and genetic study of 52 cases
8. Hemangioblastoma of the spinal cord. Review and report of five cases
9. Germ cell tumor of testis in a patient with von Hippel‐Lindau disease
10. Germ line mutations in the von Hippel‐Lindau disease tumor suppressor gene: correlations with pheno‐type
11. The natural history of renal lesions in von Hippel‐Lindau disease: a serial CT study in 28 patients
12. Histological differentiation of metastatic renal carcinoma in the cerebellum from cere‐bellar hemangioblastoma in von Hippel‐Lindau's disease
13. Posterior fossa hemangioblastomas
14. Metastatic islet cell tumor in von Hippel‐Lindau disease
15. Identification of intragenic mutations in the von Hippel‐Lindau disease tumour suppressor gene and correlation with disease phenotype
16. Von Hippel‐Lindau syndrome with bilateral synchronous renal cell carcinoma
17. Common bile duct obstruction due to pancreatic involvement in the von Hippel‐Lindau syndrome
18. A 36‐year‐old man with von Hippel‐Lindau disease and an adrenal mass. Case records of the Massachusetts General Hospital
19. A genetic linkage map of the human genome
20. Radiologic screening for von Hippel‐Lindau disease. The role of enhanced MRI in the central nervous system
21. Central nervous system involvement in von Hippel‐Lindau disease
22. Severe pancreatic involvement in three generations in von Hippel‐Lindau disease
23. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor
24. Polycystic kidneys as renal lesion in Lindau disease
25. Papillary cystadenoma of the mesosalpinx in Von Hippel‐Lindau disease
26. Screening for von Hippel‐Lindau disease by DNA polymorphism analysis
27. Von Hippel‐Lindau disease distinct phenotypes suggest more than one mutant allele at the VHL locus
28. Cerebellar hemangioblastoma and genitourinary tumors
29. Von Hippel‐Lindau disease in a Newfoundland kindred
30. Die anatomische Grundlage der von mir beschriebenen “sehr seltenen Erkrankung der Netzhaut”
31. Über eine sehr seltene Erkrankung der Netzhaut
32. Intrathoracic and multiple abdominal pheochromocytomas in von Hippel‐Lindau disease
33. Von Hippel‐Lindau disease
34. Localization of the von Hippel‐Lindau disease gene to a small region of chromosome 3
35. Phaeochromocytoma diagnosis, preoperative preparation and anaesthetic management
36. Familial islet cell tumors in von Hippel‐Lindau disease
37. Cerebellar haemangioblastoma and the von Hippel‐Lindau disease
38. The abdominal manifestation of von Hippel‐Lindau disease and a radiological screening protocol for an affected family
39. Somatic mutations of the Von Hippel‐Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas
40. Von Hippel‐Lindau Disease: New strategies in early detection and treatment
41. Von Hippel‐Lindau disease and renal cell carcinoma in a 16‐year‐old boy
42. Papillary cystadenoma of the broad ligament in von Hippel‐Lindau disease
43. CT diagnosis of unsuspected von Hippel‐Lindau disease
44. One‐megabase yeast artificial chromosome and 400‐kilobase cosmid‐phage contigs containing the von Hippel‐Lindau tumor suppressor and CA (2+)‐transporting adenosine triphosphatase isoform 2 genes
45. Von Hippel‐Lindau disease affecting 43 members of a single kindred
46. Identification of the Hippel‐Lindau disease tumor suppressor gene
47. Computed tomographic screening of the abdomen in von Hippel‐Lindau disease
48. Clinical features and natural history of von Hippel‐Lindau disease
49. Mapping of von Hippel‐Lindau disease to chromosome 3p confirmed by genetic linkage analysis
50. Von Hippel‐Lindau disease: a genetic study
51. Renal cell carcinoma in von Hippel‐Lindau syndrome
52. Lindau's disease: Review of the literature and study of a large kindred
53. Ophthalmological screening for von Hippel‐Lindau disease
54. Bilateral renal carcinoma in Von Hippel‐Lindau disease
55. Basic criteria for clinical diagnosis and genetic counselling in von Hippel‐Lindau syndrome
56. Prognosis of von Hippel‐Lindau syndrome
57. Pheochromocytomas multiple endocrine neoplasia type 2 and von Hippel‐Lindau disease
58. Pheochromocytomas, multiple endocrine neoplasia type 2 and von Hippel‐Lindau disease
59. Pancreatic lesions in the von Hippel‐Lindau syndrome
60. Central nervous system lesions in von Hippel‐Lindau syndrome
61. Hemangioblastoma of the central nervous system: a ten year study with special reference to von Hippel‐Lindau syndrome
62. Clustering of features of von Hippel‐Lindau syndrome: evidence for a complex genetic locus
63. Long‐term follow‐up after nephron sparing surgery for renal cell carcinoma in von Hippel‐Lindau disease
64. A plea for conservation of kidney in renal adenocarcinoma associated with von Hippel‐Lindau disease
65. Genetic mapping of dinucleotide repeat polymorphisms and von Hippel‐Lindau disease on chromosome 3p25–26
66. Renal transplantation in von Hippel‐Lindau disease
67. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel‐Lindau disease: Clinical and molecular genetic implications
68. Adrenal masses differentiated by MR
69. Haemangioblastoma, haemangioblas‐tomatosis and von Hippel‐Lindau disease
70. Retinal angiomatosis: the ocular manifestations of von Hippel‐Lindau disease
71. Hippel‐Lindau disease: MR imaging
72. Von Hippel‐Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
73. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of von Hippel‐Lindau disease
74. Renal pathology in von Hippel‐Lindau disease
75. Bilateral papillary cystadenoma of the epididymis as a component of von Hippel‐Lindau syndrome: Report of a case presenting as infertility
76. Surgical treatment of localized renal cell carcinoma in von Hippel‐Lindau disease
77. Von Hippel‐Lindau syndrome presenting as pancreatic endocrine insuffiency: A case report
78. Specific genetic change in tumors associated with von Hippel‐Lindau disease
79. Familial bilateral papillary cystadenoma of the epididymis: report of 3 cases in siblings
80. Urologic implications in von Hippel‐Lindau syndrome
81. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas
82. Confirmation of linkage in von Hippel‐Lindau disease
83. Von Hippel‐Lindau disease: The recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy
84. Bilateral clear cell papillary cystadenoma of the epididymis presenting as infertility: an early manifestation of von Hippel‐Lindau syndrome
85. Von Hippel‐Lindau disease: identification of deletion mutations by pulsed‐field gel electrophoresis